VITROX Analysis:-
http://lcchong.wordpress.com/2014/08/27/vi...is-27-aug-2014/
My View:-
- Fair value:
– 5Y DCF: 2.10 – 2.39 (MOS: -28% -> -13%)
– Absolute EY%:
– Trailing:
– FY13 (EPS: 0.104) – Buy below 1.15, fair value 1.37 (MOS: -97.2%)
– R4Q (EPS: 0.177) – Buy below 1.95, fair value 2.33 (MOS: -16%)
– Forward:
– FY14 (EPS: 0.18) – Buy below 1.98, fair value 2.36 (MOS: -14.2%)
– FY15 (EPS: 0.183) – Buy below 2.02, fair value 2.41 (MOS: -12%)
– EPS applied to reach the current stock price (2.7): 0.205
– At 2.7, the market assumed EPS 0.205. 0.197 is achievable based on the current outstanding booking, but this also means the current price already factored in its superb trajectory growth.
– VITROX is over valued. The current price already factored in the future earnings.
- I believe that FY14 will be a growth year for VITROX because of the recovery of global semiconductor industry and improving US, Japan and European markets.
- I still sees a lot of growth in Vitrox – the catalysts from Agilent’s exit in 2016 and competitive products should help it compete to get individual orders. But with the trend moving towards a single supplier, which provides the entire array of testing equipment that seamlessly talk to each other, Vitrox is currently being left behind. A substantial change in its internal R&D activity to innovate or potential acquisitions with talents or acquisitions with new product offerings to complement its existing portfolio, are the only ways for Vitrox to grow in the longer term.
- I will continue to hold VITROX, and will accumulate VITROX if there is correction.
Latest Financial – Q2 2014 Financial Report (21 Aug 2014) http://www.bursamalaysia.com/market/listed...cements/1716629
At the time of writing, I owned shares of VITROX.
My Own Research
Aug 27 2014, 09:50 PM
Quote
0.0272sec
0.67
5 queries
GZIP Disabled